Connecting Research and Experts with Journalists

• share
• favorite_border

A cosmic question mark?

• share
• favorite_border

Metal organic frameworks (MOFs) show promise as a way to trap toxic molecules and mitigate their harmful effects. In this research, scientists studied how the structure of MOFs can be tuned to enhance and optimize trapping of nitrogen dioxide and sulfur dioxide.

• share
• favorite_border

It’s challenging to achieve significant curve correction during a spinal fusion “graduation” surgery for children with early onset scoliosis. Over the years, bone auto-fuses and stiffens around growing rods—making the spine tougher to straighten during this final procedure.

• share
• favorite_border

Transgender and gender diverse (TGD) youth are more than five times more likely to screen positive for suicide risk compared to cisgender females, who tend to screen positive at higher rates than cisgender males, according to a study from Ann & Robert H. Lurie Children’s Hospital of Chicago published in the journal Academic Pediatrics.

• share
• favorite_border

Argonne contributes to landmark research that could lead to better cathodes for longer-lasting lithium-ion batteries.

• share
• favorite_border

A drug that delivers chemotherapy directly to tumors has shown impressive activity against some of the hardest-to-reach cancer cells: those that have spread to the brain in patients with advanced HER2-positive breast cancer. Research led by Dana-Farber Cancer Institute.

• share
• favorite_border

Mount Sinai study could lead to new treatments for fibromuscular dysplasia

• share
• favorite_border

A pioneering method for soil moisture retrieval using satellite navigation systems has been introduced, significantly boosting the accuracy and efficiency of global data collection.

• share
• favorite_border

In an international multicenter randomized phase 3 clinical trial led by Dana-Farber Cancer Institute, researchers tested the addition of the immune checkpoint inhibitor (ICI) nivolumab to treatment with tivozanib for patients with advanced clear cell renal cell carcinoma.